Is it acceptable to approach colorectal cancer patients at diagnosis to discuss genetic testing? A pilot study.
In this pilot study, the acceptability of approaching 111 newly diagnosed colorectal cancer patients with the offer of genetic testing for hereditary nonpolyposis colorectal cancer (HNPCC) was assessed. A total of 78% of participants found it highly acceptable to have the information about HNPCC brought to their attention at that time.
Porteous
M
M
Department of Clinical Genetics, Molecular Medicine Centre, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK. mary.porteous@ed.ac.uk
Dunckley
M
M
Appleton
S
S
Catt
S
S
Dunlop
M
M
Campbell
H
H
Cull
A
A
D000328:Adult; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000235:genetics*; D003123:Colorectal Neoplasms, Hereditary Nonpolyposis / Q000175:diagnosis* / Q000235:genetics*; D005260:Female; D005820:Genetic Testing; D006801:Humans; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D010358:Patient Participation; D017060:Patient Satisfaction; D012307:Risk Factors